Viola Pomozi

Dr. Viola Pomozi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 November 2021 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
EKEszter Kozak
Eszter Kozak
KFKrisztina Fülöp
Krisztina Fülöp
NTNatália Tőkési
Natália Tőkési
NRNidhi Rao
Nidhi Rao
QLQiaoli Li
Qiaoli Li
VPViola Pomozi
Viola Pomozi

15 February 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
CBChristopher Brampton
Christopher Brampton
VPViola Pomozi
Viola Pomozi
YCYannick Le Corre
Yannick Le Corre
JZJanna Zoll
Janna Zoll
GKGilles Kauffenstein
Gilles Kauffenstein
OSOlivier Le Saux
Olivier Le Saux

17 August 2024 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
VPViola Pomozi
Viola Pomozi
STSharon F Terry
Sharon F Terry
AVAndrás Váradi
András Váradi

13 October 2025 in FEBS Open Bio
Verified
Journal Article
Open access
KFKrisztina Fülöp
Krisztina Fülöp
EKEszter Kozák
Eszter Kozák
NTNatália Tőkési
Natália Tőkési
LKLilian Kocsis
Lilian Kocsis
AKAnikó Kelemen
Anikó Kelemen
VPViola Pomozi
Viola Pomozi
The predominant cause of death among diabetic patients comes from cardiovascular complications, including vascular calcification. The objectives of this study were to improve the understanding of the molecular mechanisms involved in diabetes‐related calcification and to test potential preventive therapies. We found that levels of plasma pyrophosphate—a potent inhibitor of calcification—were decreased in type 1 and type 2 diabetic patients with cardiovascular symptoms. To further investigate vascular calcification, we developed a diabetic mouse model that showed increased aorta and renal calcification compared to control. Alkaline phosphatase activity was also increased in the circulation of diabetic mice, which resulted in a significant decrease in plasma pyrophosphate. Oral treatment with pyrophosphate prevented diabetes‐induced calcification in mice, providing a direct translational value for clinical applications.

Verified
Journal Article
Open access
PDF file
AKAdriána Kutás
Adriána Kutás
VPViola Pomozi
Viola Pomozi
KFKrisztina Fülöp
Krisztina Fülöp
BVBéla Viskolcz
Béla Viskolcz
AGAttila Garami
Attila Garami
Csaba VáradiCsaba Váradi
Csaba Váradi
The rising global incidence of Type 1 Diabetes Mellitus (T1DM) necessitates a deeper understanding of the molecular shifts underlying its metabolic complications, specifically the role of protein N-glycosylation. This study utilized a streptozotocin-induced C57Bl/6 mouse model to examine temporal changes in plasma N-glycan profiles at 2, 8, and 20 weeks post-induction using HILIC-UPLC-FLR-MS. Following the successful establishment of persistent hyperglycemia and weight loss, glycomic analysis revealed significant structural remodeling of 20 individual glycan species, with complex, multi-sialylated structures proving most sensitive to disease progression. Notably, bi-antennary structures such as A2G1S1, A2G2S1, and A2G2S2(2) exhibited a marked decrease in relative abundance that strongly correlated with elevated blood glucose levels. In contrast, highly sialylated and fucosylated glycans like FA2G2S3 and FA3G3S3 showed a progressive increase over the 20-week period, suggesting an adaptive response to chronic metabolic stress and altered hepatic processing. Our findings demonstrate that chronic hyperglycemia is accompanied by substantial remodeling of the plasma N-glycome, characterized by increased sialylation and fucosylation. These alterations closely track the progression of metabolic dysregulation, suggesting that while they parallel blood glucose trends, they provide a distinct molecular readout of the systemic glycosylation response to glucotoxicity. This study offers a detailed longitudinal characterization of these glycomic changes, highlighting their potential value as descriptive markers of cumulative metabolic stress in rodent models of type 1 diabetes.

27 July 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
DCDávid Czimer
Dávid Czimer
PKPanna Kaluzsa
Panna Kaluzsa
JKJózsef Kövendi
József Kövendi
LLLuca Kamilla Li
Luca Kamilla Li
BKBlanka Kapusi
Blanka Kapusi
Máté VargaMáté Varga
Máté Varga
Quantifying skeletal mineralization phenotypes in larval fish is complicated by the natural curvature of the notochord and by sample-to-sample variability in orientation, staining and imaging. Consequently, many studies rely on summary measures such as vertebral counts or total stain intensity. Here we present SCAMP (Spinal Calcification & Mineralization Profiler), an open-source, GUI-based Python tool that computationally straightens the curved notochord of Alizarin Red S-stained fish larvae and generates standardized ARS-based mineralization profiles along the spinal axis. This approach reduces positional and shape variability, allowing direct quantitative comparison of Alizarin Red S fluorescence patterns within experimental cohorts processed and imaged under matched conditions, without requiring programming expertise. We validate SCAMP using a zebrafish model of Pseudoxanthoma elasticum ( abcc6a elu15/elu15 ), recovering genotype-specific differences in the intensity, extent and spatial distribution of ectopic mineralization. Using SCAMP, we further show that inorganic pyrophosphate supplementation reduces ectopic intervertebral Alizarin Red S signal, alters the anterior-posterior distribution of mineralized regions in homozygous mutants, and increases signal at physiological chordacentrum positions. We also show that methylene blue, a routine antifungal additive in fish medium, is associated with reduced baseline Alizarin Red S-based mineralization endpoints, with the most pronounced effects observed in heterozygous controls. SCAMP is freely available and has the potential to be adapted to other fish species used in skeletal and mineralization research.